Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Burroughs Amy L., Director. Officer active across 2 companies, notably DiaMedica Therapeutics Inc.. In total, 10 filings have been logged. Split: 4 buys · 0 sell. Total volume traded: €305k. History available since 16 August 2021. The latest transaction was disclosed on 16 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Burroughs Amy L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
44,950 shares@ US$3.1566.8% of flowVoting Common Shares, no par value per shareSEC:0001235802-21-000101:0
Canonical exit: 14 Nov 2021 (T+90)
10 of 10 declarations
About Burroughs Amy L.
Burroughs Amy L. is Administrateur at Terns Pharmaceuticals, Inc. and Director at DiaMedica Therapeutics Inc. She has 10 filings in total, and across the 10 recent filings tracked, buys total EUR 304958 with no sales, with filings dated from 2021-08-17 to 2026-03-17.